Adenosine Therapeutics, LLC
Drug discovery firm announces $3.5M in funding
Published in Healthcare Mergers, Acquisitions and Ventures Week, February 26th, 2005
The additional capital will support the firm's overall growth. Williams Mullen served as legal counsel to the company for the offering.
One immediate use of the added funds is the expansion of the company's laboratory capability. Research space has been doubled and the program has been strengthened with the purchase of equipment to conduct nuclear magnetic resonance spectrometer studies.
"This funding will allow Adenosine Therapeutics to enhance our discovery capabilities...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- ATS Medical, Inc.
Medical device maker reports 28% increase in revenue - Accelerator Corporation
Cancer-focused Spaltudaq is third biotech company started by venture corporation - Accelrys, Inc.
Device firm reports decline in revenue - Advanced Cell Technology
New CEO, chief scientific officer named at biotech firm - Advanced Magnetics, Inc.
Pharmaceutical firm reports loss of $0.32 per share - Advanced Medical Optics, Inc.
Ophthalmology firm reports 23% increase in revenue - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
